2008-08-20 08:26:36 -

Keynote Speaker Dr. Mike Romanos, Vice President of Discovery Technologies at GlaxoSmithKline will give an overview of biomarker discovery for translational studies at this year's Biomarker Discovery Europe forum.
At the conference Dr. Romanos will discuss the current issues and bottlenecks in the discovery, validation and application of biomarkers. He will also cover specific case studies from biomarker projects at

GlaxoSmithKline. For more information on Dr. Romanos' presentation visit gtcbio.com/userAgenda.aspx?id=130.
Biomarker Discovery Europe 2008 taking place on October 2-3, 2008 in Dublin, Ireland will create a forum whereby industry leaders from the US, Europe, and Asia can collaborate and explore some of the differences between the US and European R & D environment. New technologies used to expedite the discovery to validation process as well as the usage of biomarkers in clinical trial design will be highlighted. A unique look at the practical issues and concerns with the role of biomarkers in personalized medicine will also be addressed. For more information visit gtcbio.com/conferenceDetails.aspx?id=130.

ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.

Contact: GTCBIO 434 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 256-6460 email: jason.yi@gtcbio.com